Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature review
Hiroshi Yokouchi(National Hospital Organization Hokkaido Medical Center), Masaharu Nishimura(Hokkaido Institute of Public Health)
Cited by 17
Related Papers
Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402
|Journal of Clinical Oncology|2008|235
γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
|British Journal of Cancer|2012|49
Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family
|PLoS ONE|2019|8
Identification of chronic obstructive pulmonary disease subgroups in 13 Asian cities
|The International Journal of Tuberculosis and Lung Disease|2018|7